How can doctors discuss CLL treatment options with patients?
Choosing treatment options for CLL and combining novel drugs
The impact of genetic testing on treatment selection in CLL
Overview of 3 studies on CLL therapy: data on ibrutinib and a ROR1 inhibitor
Obinutuzumab (GA101) plus bendamustine as front-line therapy in CLL